The Future of Falsified and Substandard Medicine Detection: Digital Methods To Track and Authenticate Pharmaceutical Products

The Future of Falsified and Substandard Medicine Detection: Digital Methods To Track and Authenticate Pharmaceutical Products

This case study and associated publications (Naughton et al., 2017, 2016) paint a picture of a technically sound, planned digital solutions to address the problem presented by substandard and falsified medicines, which appear to be growing internationally, particularly as purchases increasingly take...

Descripció completa

Dades bibliogràfiques
Autor principal:	Naughton, B
Format:	Record
Publicat:	Pathways for Prosperity Commission 2018

Ítems similars

Trade in substandard and falsified medicines
per: Hagen, N, et al.
Publicat: (2022)

Substandard and Falsified Medicines in Myanmar
per: Mirai Sakuda, et al.
Publicat: (2020-03-01)

Identification of substandard and falsified medicines: influence of different tolerance limits and use of authenticity inquiries
per: Hauk, C, et al.
Publicat: (2021)

How to achieve international action on falsified and substandard medicines.
per: Attaran, A, et al.
Publicat: (2012)

Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance
per: Elizabeth Pisani, et al.
Publicat: (2021-08-01)

The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists
per: Veronika J Wirtz, et al.
Publicat: (2019-07-01)

Combatting substandard and falsified medicines: a view from Rwanda.
per: Agnes Binagwaho, et al.
Publicat: (2013-01-01)

Substandard, falsified and unregistered medicines in Latin America, 2017-2018
per: Robin Rojas-Cortés
Publicat: (2020-10-01)

Quantitative screening of the pharmaceutical ingredient for the rapid identification of substandard and falsified medicines using reflectance infrared spectroscopy.
per: Graham Lawson, et al.
Publicat: (2018-01-01)

The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
per: Cavany, S, et al.
Publicat: (2023)

The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
per: Sean Cavany, et al.
Publicat: (2023-10-01)

Falsified and substandard medicines trafficking: A wakeup call for the African continent
per: Yusuf Hassan Wada, et al.
Publicat: (2022-06-01)

Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
per: Faris El-Dahiyat, et al.
Publicat: (2021-10-01)

A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies: a focus on context, prevalence, and quality
per: McManus, D, et al.
Publicat: (2020)

Tackling the global impact of substandard and falsified and unregistered/unlicensed anti-tuberculosis medicines
per: Tamara Akpobolokemi, et al.
Publicat: (2022-01-01)

A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies: a focus on context, prevalence, and quality
per: Dominic McManus, et al.
Publicat: (2020-08-01)

Technologies for detecting falsified and substandard drugs in low and middle-income countries.
per: Stephanie Kovacs, et al.
Publicat: (2014-01-01)

Mobile apps for detecting falsified and substandard drugs: A systematic review.
per: Agustín Ciapponi, et al.
Publicat: (2021-01-01)

Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?
per: Zabala, GA, et al.
Publicat: (2022)

Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?
per: Paul N Newton, et al.
Publicat: (2022-08-01)

The economic impact of substandard and falsified antimalarial medications in Nigeria.
per: Sarah M Beargie, et al.
Publicat: (2019-01-01)

The concept of substandard (falsified and poor quality) industrial products and its types
per: K. A. Utarov, et al.
Publicat: (2022-09-01)

The concept of substandard (falsified and poor quality) industrial products and its types
per: K. A. Utarov, et al.
Publicat: (2022-09-01)

Substandard and falsified medical products: bibliometric analysis and mapping of scientific research
per: Waleed M. Sweileh
Publicat: (2021-09-01)

Exploring pharmacists' perspectives about substandard and falsified medical products through interviews
per: A. Persson, et al.
Publicat: (2024-03-01)

A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
per: Tabernero, P, et al.
Publicat: (2019)

A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
per: Tabernero, P, et al.
Publicat: (2022)

Prevalence of substandard, falsified, unlicensed and unregistered medicine and its associated factors in Africa: a systematic review
per: Biset Asrade Mekonnen, et al.
Publicat: (2024-12-01)

A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country
per: Daariimaa Khurelbat, et al.
Publicat: (2020-05-01)

Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
per: Albert Petersen, et al.
Publicat: (2017-01-01)

Prevention, Detection and Response to incidences of substandard and falsified medical products in the Member States of the Southern African Development Community
per: Stanislav Kniazkov, et al.
Publicat: (2020-12-01)

Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study.
per: Colleen R Higgins, et al.
Publicat: (2023-01-01)

Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study
per: Colleen R. Higgins, et al.
Publicat: (2023-01-01)

Substandard and falsified antimicrobials in selected east African countries: A systematic review.
per: Addisu Afrassa Tegegne, et al.
Publicat: (2024-01-01)

Substandard and falsified antimicrobials in selected east African countries: A systematic review
per: Addisu Afrassa Tegegne, et al.
Publicat: (2024-01-01)

Cost savings of paper analytical devices (PADs) to detect substandard and falsified antibiotics: Kenya case study
per: Hui-Han Chen, et al.
Publicat: (2021-03-01)

The EU Falsified Medicines Directive: key implications for dispensers
per: Naughton, B
Publicat: (2017)

Unveiling the Peril of Substandard and Falsified Medicines to Public Health and Safety in Africa: Need for All-Out War to End the Menace
per: Nafiu Aminu, et al.
Publicat: (2017-01-01)

Establishing good authentication practice (GAP) in secondary care to protect against falsified medicines and improve patient safety
per: Naughton, B, et al.
Publicat: (2016)

Screening for substandard and falsified medicines in Nigeria using visual inspection and GPHF-Minilab analysis: lessons learnt for future training of health workers and pharmacy personnel
per: Micha Lächele, et al.
Publicat: (2024-12-01)